文献速递心胸血管麻醉

右美托咪定对绵羊体外循环中肾脑微循环及组织学的影响

Effects of dexmedetomidine on kidney and brain tissue microcirculation and histology in ovine cardiopulmonary bypass: a randomised controlled trial.
PubMed 文献 · Anaesthesia · 2023-10-25

该随机对照试验在绵羊体外循环模型中发现,右美托咪定虽未改善肾髓质组织氧合,也未减少脑神经炎症,但接受右美托咪定的绵羊肾小管组织学损伤发生率更高(7/8 vs 2/8,p=0.041),且损伤严重度评分更高(中位数1.5 vs 0,p=0.013),肾功能未见差异。

要点

  • 右美托咪定未减轻体外循环期间肾髓质缺氧。
  • 右美托咪定组肾小管组织学损伤发生率与严重度均更高。
  • 两组脑组织微胶质细胞活化(神经炎症)无差异。

核心结论

  • 在绵羊体外循环模型中,右美托咪定未减少肾髓质缺氧或脑神经炎症,且与更频繁和更严重的肾小管组织学损伤相关。

主要发现

  • 体外循环开始后,安慰剂组肾髓质组织氧合从平均(95%CI)5.96(4.24-7.23)kPa降至1.56(0.84-2.09)kPa(p=0.001),右美托咪定组从6.33(5.33-7.07)kPa降至1.51(0.33-2.39)kPa(p=0.002)。
  • 接受右美托咪定绵羊肾小管组织学损伤发生率为7/8,安慰剂组为2/8(p=0.041)。
  • 按半定量量表(0-3分)评估,右美托咪定组肾小管损伤严重度中位数(IQR[范围])为1.5(1-2[0-3]),安慰剂组为0(0-0.3[0-1])(p=0.013)。
  • 两组肾功能(肌酐清除率下降)未见明显差异,脑组织微胶质细胞活化(神经炎症)无组间差异。

临床怎么用

  • 该动物实验提示右美托咪定在体外循环期间未显示肾脏保护作用,且可能加重肾小管组织学损伤,临床决策需权衡利弊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiac surgery requiring cardiopulmonary bypass is associated with postoperative acute kidney injury and neurocognitive disorders, including delirium. Intra-operative inflammation and/or impaired tissue perfusion/oxygenation are thought to be contributors to these outcomes. It has been hypothesised that these problems may be ameliorated by the highly selective α2 -agonist, dexmedetomidine. We tested the effects of dexmedetomidine on renal and cerebral microcirculatory tissue perfusion, oxygenation and histology in a clinically relevant ovine model. Sixteen sheep were studied while conscious, after induction of anaesthesia and during 2 h of cardiopulmonary bypass. Eight sheep were allocated randomly to receive an intravenous infusion of dexmedetomidine (0.4-0.8 μg.kg-1 .h-1 ) from induction of anaesthesia to the end of cardiopulmonary bypass, and eight to receive an equivalent volume of matched placebo (0.9% sodium chloride). Commencement of cardiopulmonary bypass decreased renal medullary tissue oxygenation in the placebo group (mean (95%CI) 5.96 (4.24-7.23) to 1.56 (0.84-2.09) kPa, p = 0.001), with similar hypoxic levels observed in the dexmedetomidine group (6.33 (5.33-7.07) to 1.51 (0.33-2.39) kPa, p = 0.002). While no differences in kidney function (i.e. reduced creatinine clearance) were evident, a greater incidence of histological renal tubular injury was observed in sheep receiving dexmedetomidine (7/8 sheep) compared with placebo (2/8 sheep), p = 0.041. Graded on a semi-quantitative scale (0-3), median (IQR [range]) severity of histological renal tubular injury was higher in the dexmedetomidine group compared with placebo (1.5 (1-2 [0-3]) vs. 0 (0-0.3 [0-1]) respectively, p = 0.013). There was no difference in cerebral tissue microglial activation (neuroinflammation) between the groups. Dexmedetomidine did not reduce renal medullary hypoxia or cerebral neuroinflammation in sheep undergoing cardiopulmonary bypass.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Jufar AH, May CN, Booth LC, et al. Effects of dexmedetomidine on kidney and brain tissue microcirculation and histology in ovine cardiopulmonary bypass: a randomised controlled trial. Anaesthesia. 2023. PMID: 37880924. doi:10.1111/anae.16152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。